BlackRock Institutional Trust Company lowers AmSurg stake by 0.2% — 5 quick facts

During the third quarter of fiscal year 2016, BlackRock Institutional Trust Company reduced its stake in Nashville, Tenn.-based AmSurg by 0.2 percent, according to Daily Quint.

Advertisement

Here are five quick facts:

1. BlackRock sold 2,512 AmSurg shares during the quarter.

2. At the quarter’s end, the firm’s stake in AmSurg totaled nearly $106.33 million.

3. AmSurg reported earnings per share of $1.13 during Q3.

4. The ASC company generated revenue reaching $822.2 million for the quarter.

5. On Sept. 26, 2016, Citigroup rated AmSurg shares a “buy.”

More articles on ambulatory surgery centers:
Physicians Endoscopy joint ventures on 43rd ASC; Surgery Partners’ market cap hits $282.6M & more — 5 ASC company notes
Ann & Robert H. Lurie Children’s Hospital of Chicago obtains CON approval for surgery center: 5 highlights
Mednax makes way into radiology space through Radiology Alliance acquisition: 5 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.